BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 30715618)

  • 1. Recent Development of Wnt Signaling Pathway Inhibitors for Cancer Therapeutics.
    Harb J; Lin PJ; Hao J
    Curr Oncol Rep; 2019 Feb; 21(2):12. PubMed ID: 30715618
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Wnt signaling in breast cancer: biological mechanisms, challenges and opportunities.
    Xu X; Zhang M; Xu F; Jiang S
    Mol Cancer; 2020 Nov; 19(1):165. PubMed ID: 33234169
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cell biology. The unusual case of Porcupine.
    Lum L; Clevers H
    Science; 2012 Aug; 337(6097):922-3. PubMed ID: 22923569
    [TBL] [Abstract][Full Text] [Related]  

  • 4. New drugs are not enough‑drug repositioning in oncology: An update.
    Armando RG; Mengual Gómez DL; Gomez DE
    Int J Oncol; 2020 Mar; 56(3):651-684. PubMed ID: 32124955
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A novel method of transcriptional response analysis to facilitate drug repositioning for cancer therapy.
    Jin G; Fu C; Zhao H; Cui K; Chang J; Wong ST
    Cancer Res; 2012 Jan; 72(1):33-44. PubMed ID: 22108825
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Wnt Signaling and Drug Resistance in Cancer.
    Zhong Z; Virshup DM
    Mol Pharmacol; 2020 Feb; 97(2):72-89. PubMed ID: 31787618
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The CLK inhibitor SM08502 induces anti-tumor activity and reduces Wnt pathway gene expression in gastrointestinal cancer models.
    Tam BY; Chiu K; Chung H; Bossard C; Nguyen JD; Creger E; Eastman BW; Mak CC; Ibanez M; Ghias A; Cahiwat J; Do L; Cho S; Nguyen J; Deshmukh V; Stewart J; Chen CW; Barroga C; Dellamary L; Kc SK; Phalen TJ; Hood J; Cha S; Yazici Y
    Cancer Lett; 2020 Mar; 473():186-197. PubMed ID: 31560935
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Wnt/PCP Signaling Contribution to Carcinoma Collective Cell Migration and Metastasis.
    VanderVorst K; Dreyer CA; Konopelski SE; Lee H; Ho HH; Carraway KL
    Cancer Res; 2019 Apr; 79(8):1719-1729. PubMed ID: 30952630
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Wnt Signaling in the Regulation of Immune Cell and Cancer Therapeutics.
    Haseeb M; Pirzada RH; Ain QU; Choi S
    Cells; 2019 Nov; 8(11):. PubMed ID: 31684152
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Wnt signaling pathway: a potential therapeutic target against cancer.
    Ghosh N; Hossain U; Mandal A; Sil PC
    Ann N Y Acad Sci; 2019 May; 1443(1):54-74. PubMed ID: 31017675
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mechanisms of intercellular Wnt transport.
    Routledge D; Scholpp S
    Development; 2019 May; 146(10):. PubMed ID: 31092504
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A phase 1b dose escalation study of Wnt pathway inhibitor vantictumab in combination with nab-paclitaxel and gemcitabine in patients with previously untreated metastatic pancreatic cancer.
    Davis SL; Cardin DB; Shahda S; Lenz HJ; Dotan E; O'Neil BH; Kapoun AM; Stagg RJ; Berlin J; Messersmith WA; Cohen SJ
    Invest New Drugs; 2020 Jun; 38(3):821-830. PubMed ID: 31338636
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Many tumors induced by the mouse mammary tumor virus contain a provirus integrated in the same region of the host genome.
    Nusse R; Varmus HE
    Cell; 1982 Nov; 31(1):99-109. PubMed ID: 6297757
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transcriptional Regulation of Wnt/β-Catenin Pathway in Colorectal Cancer.
    Bian J; Dannappel M; Wan C; Firestein R
    Cells; 2020 Sep; 9(9):. PubMed ID: 32961708
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Wnt/β-catenin signalling in ovarian cancer: Insights into its hyperactivation and function in tumorigenesis.
    Nguyen VHL; Hough R; Bernaudo S; Peng C
    J Ovarian Res; 2019 Dec; 12(1):122. PubMed ID: 31829231
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Wnt Signaling in Cancer: Not a Binary ON:OFF Switch.
    Flanagan DJ; Vincan E; Phesse TJ
    Cancer Res; 2019 Dec; 79(23):5901-5906. PubMed ID: 31431458
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mutations and mechanisms of WNT pathway tumour suppressors in cancer.
    Bugter JM; Fenderico N; Maurice MM
    Nat Rev Cancer; 2021 Jan; 21(1):5-21. PubMed ID: 33097916
    [TBL] [Abstract][Full Text] [Related]  

  • 18. WNT Signaling in Tumors: The Way to Evade Drugs and Immunity.
    Martin-Orozco E; Sanchez-Fernandez A; Ortiz-Parra I; Ayala-San Nicolas M
    Front Immunol; 2019; 10():2854. PubMed ID: 31921125
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Decoding Dishevelled-Mediated Wnt Signaling in Vertebrate Early Development.
    Shi DL
    Front Cell Dev Biol; 2020; 8():588370. PubMed ID: 33102490
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Noncanonical Wnt planar cell polarity signaling in lung development and disease.
    Vladar EK; Königshoff M
    Biochem Soc Trans; 2020 Feb; 48(1):231-243. PubMed ID: 32096543
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.